Showing 1 - 20 results of 28 for search 'Giovanni Taccetti', query time: 0.08s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Modulator Therapy in Cystic Fibrosis Patients with <i>cis</i> Variants in F508del Complex Allele: A Short-Term Observational Case Series by Vito Terlizzi, Claudia Centrone, Beatrice Ferrari, Chiara Castellani, Tarini N. A. Gunawardena, Giovanni Taccetti, Onofrio Laselva
Published 2022-08-01
Article -
11
Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive... by Daniela Dolce, Cristina Fevola, Erica Camera, Tommaso Orioli, Ersilia Lucenteforte, Marco Andrea Malanima, Giovanni Taccetti, Vito Terlizzi
Published 2023-07-01
Article -
12
Extensive <i>CFTR</i> Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers by Maria Valeria Esposito, Achille Aveta, Marika Comegna, Gustavo Cernera, Paola Iacotucci, Vincenzo Carnovale, Giovanni Taccetti, Vito Terlizzi, Giuseppe Castaldo
Published 2020-11-01
Article -
13
Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype by Marika Comegna, Vito Terlizzi, Donatello Salvatore, Carmela Colangelo, Antonella Miriam Di Lullo, Immacolata Zollo, Giovanni Taccetti, Giuseppe Castaldo, Felice Amato
Published 2021-07-01
Article -
14
A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening by Antonella Tosco, Diletta Marino, Sara Polizzi, Valentina Tradati, Rita Padoan, Claudia Giust, Benedetta Fabrizzi, Giovanni Taccetti, Lucia Merli, Vito Terlizzi
Published 2023-01-01
Article -
15
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical... by Alice Castaldo, Alice Castaldo, Alice Castaldo, Monica Gelzo, Monica Gelzo, Paola Iacotucci, Annalisa Longobardi, Giovanni Taccetti, Vito Terlizzi, Vincenzo Carnovale
Published 2024-01-01
Article -
16
Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy by Giovanni Taccetti, Matteo Botti, Vito Terlizzi, Maria Chiara Cavicchi, Anna Silvia Neri, Valeria Galici, Gianfranco Mergni, Claudia Centrone, Diego G. Peroni, Filippo Festini
Published 2020-07-01
Article -
17
CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development? by Vito Terlizzi, Rita Padoan, Laura Claut, Carla Colombo, Benedetta Fabrizzi, Marco Lucarelli, Sabina Maria Bruno, Alice Castaldo, Paolo Bonomi, Giovanni Taccetti, Antonella Tosco
Published 2020-12-01
Article -
18
Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagno... by Chiara Bianchimani, Daniela Dolce, Claudia Centrone, Silvia Campana, Novella Ravenni, Tommaso Orioli, Erica Camera, Gianfranco Mergni, Cristina Fevola, Paolo Bonomi, Giovanni Taccetti, Vito Terlizzi
Published 2022-08-01
Article -
19
Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators by Vito Terlizzi, Emanuela Pesce, Valeria Capurro, Valeria Tomati, Mariateresa Lena, Cristina Pastorino, Renata Bocciardi, Federico Zara, Claudia Centrone, Giovanni Taccetti, Carlo Castellani, Nicoletta Pedemonte
Published 2023-03-01
Article -
20
Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present by Matteo Botti, Vito Terlizzi, Michela Francalanci, Daniela Dolce, Maria Chiara Cavicchi, Anna Silvia Neri, Valeria Galici, Gianfranco Mergni, Lucia Zavataro, Claudia Centrone, Filippo Festini, Giovanni Taccetti
Published 2021-01-01
Article